Related Experiment Video
Updated: Jul 4, 2026
A Protocol for the Administration of Real-Time fMRI Neurofeedback Training
Published on: August 24, 2017
[Therapy of tinnitus in children]
Danuta Gryczyńska1, Katarzynca Drobik-Wasiewicz, Małgorzata Malicka
1Klinika Otolaryngologii, Audiologii i Foniatrii Dzieciecej Uniwersytetu Medycznego w Lodzi.
Insights
Childhood tinnitus is common when assessed, though rarely reported spontaneously. Betahistine treatment proved effective for pediatric tinnitus, particularly in children without hearing loss.
Area of Science:
- Pediatric Otolaryngology
- Audiology
- Pharmacology
Background:
- Tinnitus in children is frequently underreported, often only identified through direct questioning.
- Childhood tinnitus presents a diagnostic challenge due to the lack of spontaneous complaints.
Purpose of the Study:
- To evaluate the efficacy of betahistine in treating tinnitus in children.
- To compare treatment outcomes between children with and without associated hearing loss.
Main Methods:
- A cohort of 67 children (aged 6-18) with tinnitus was studied.
- Evaluations included medical history, otolaryngologic, neurologic, psychologic, and audiologic assessments.
- Betahistine (Betaserc) was administered to 55 children after excluding 12 with conductive hearing loss.
Main Results:
- Betahistine demonstrated positive therapeutic effects in pediatric tinnitus cases.
- The study suggests betahistine is a beneficial drug for managing tinnitus in children.
Conclusions:
- Betahistine is an effective pharmacological intervention for childhood tinnitus.
- Further research may explore betahistine's specific benefits in tinnitus subgroups.
Abstract:
Tinnitus in childhood is quite common when children are directly asked about this syndrom. Children rarely spontaneously complain of tinnitus. Material consists of 67 children (6-18 year old) with tinnitus, treated in the Pediatric Otolaryngology Clinic and Outpatient. Between children there were 2 groups: I tinnitus connected with hearing loss--35 children, II tinnitus without hearing loss--32 children. Methods. Anamnesis, otolaryngologic, neurologic, psychologic examinations, panel of audiologic tests before and after treatment of betahistine. In 12 patients there were recognized conductive hearing loss and they were excluded from therapy of betahistine. 55 children were treated with betahistine (Betaserc). Results indicates that betahistine is a good drug in therapy of tinnitus in children.
